HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Malcolm V Brock Selected Research

3-chloro-2,5,6-trimethylbenzoate

1/2020Multimodal genomic features predict outcome of immune checkpoint blockade in non-small-cell lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Malcolm V Brock Research Topics

Disease

31Neoplasms (Cancer)
10/2021 - 03/2002
19Lung Neoplasms (Lung Cancer)
10/2021 - 12/2004
9Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2020 - 01/2004
7Esophageal Neoplasms (Esophageal Cancer)
01/2015 - 11/2006
5Colorectal Neoplasms (Colorectal Cancer)
02/2022 - 09/2007
5Adenocarcinoma
03/2020 - 05/2002
4Stomach Neoplasms (Stomach Cancer)
02/2022 - 01/2014
3Neoplasm Metastasis (Metastasis)
01/2020 - 07/2005
3Carcinogenesis
05/2013 - 12/2003
2Hodgkin Disease (Hodgkin's Disease)
01/2021 - 10/2019
2Pneumonia (Pneumonitis)
07/2016 - 04/2016
2Carcinoma (Carcinomatosis)
05/2015 - 06/2007
1Postgastrectomy Syndromes
02/2022
1Body Weight (Weight, Body)
01/2022
1Atherosclerosis
01/2022
1Granuloma
10/2021
1Pancreatic Neoplasms (Pancreatic Cancer)
03/2020
1Residual Neoplasm
01/2019
1Hyperhidrosis
11/2018
1Inflammation (Inflammations)
09/2017
1Neutropenia
01/2017
1Anemia
01/2017
1Anorexia
01/2017
1Fatigue
01/2017
1Nausea
01/2017
1Ovarian Neoplasms (Ovarian Cancer)
01/2017
1Infections
07/2016
1Pulmonary Embolism
04/2016
1Hepatocellular Carcinoma (Hepatoma)
05/2015
1Squamous Cell Neoplasms (Squamous Cell Cancer)
01/2015
1Multiple Endocrine Neoplasia Type 2a (MEN 2)
04/2013
1Hematologic Neoplasms (Hematological Malignancy)
03/2012
1Disease Progression
12/2011
1Neoplasm Micrometastasis
11/2011
1Necrosis
02/2010

Drug/Important Bio-Agent (IBA)

15DNA (Deoxyribonucleic Acid)IBA
01/2020 - 08/2004
9DecitabineFDA Link
01/2021 - 11/2006
5Biomarkers (Surrogate Marker)IBA
03/2020 - 12/2011
4Pharmaceutical PreparationsIBA
02/2022 - 10/2006
4Immune Checkpoint InhibitorsIBA
01/2021 - 01/2017
3ParaffinIBA
03/2020 - 02/2014
3Paclitaxel (Taxol)FDA LinkGeneric
01/2017 - 01/2014
3Docetaxel (Taxotere)FDA Link
04/2015 - 01/2015
3Azacitidine (5 Azacytidine)FDA Link
11/2013 - 12/2011
2camrelizumabIBA
01/2021 - 10/2019
2Circulating Tumor DNAIBA
01/2019 - 09/2017
2PlatinumIBA
01/2017 - 01/2005
2Fluorouracil (Carac)FDA LinkGeneric
05/2015 - 01/2014
2CateninsIBA
06/2013 - 11/2012
2SmokeIBA
05/2013 - 03/2006
2LuciferasesIBA
11/2012 - 07/2012
2Cyclin-Dependent Kinase Inhibitor p16IBA
03/2008 - 12/2003
1Irinotecan (Camptosar)FDA LinkGeneric
02/2022
1Apolipoproteins E (ApoE)IBA
01/2022
1nitrosamine 4- (methylnitrosamino)- 1- (3- pyridyl)- 1- butanoneIBA
12/2020
1DNA AdductsIBA
12/2020
1protachykininIBA
03/2020
1Cysteine Dioxygenase (Dioxygenase, Cysteine)IBA
03/2020
1Formaldehyde (Formol)FDA Link
03/2020
13-chloro-2,5,6-trimethylbenzoateIBA
01/2020
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2020
1Therapeutic UsesIBA
01/2019
1AntibodiesIBA
01/2017
1Carboplatin (JM8)FDA LinkGeneric
01/2017
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2017
1Tumor Suppressor Protein p14ARF (p14ARF)IBA
12/2015
1Oxaliplatin (Eloxatin)FDA LinkGeneric
04/2015
1taxaneIBA
01/2015
1Transforming Growth Factors (Transforming Growth Factor)IBA
12/2014
1trichostatin A (A 300)IBA
04/2014
1hydrogen sulfite (bisulfite)IBA
02/2014
1Cisplatin (Platino)FDA LinkGeneric
01/2014
1Tumor Biomarkers (Tumor Markers)IBA
10/2013
1Cell-Free Nucleic AcidsIBA
10/2013
1ChemokinesIBA
10/2013
1CarcinogensIBA
05/2013
1Estrogens (Estrogen)FDA Link
04/2013
1ErbB Receptors (EGF Receptor)IBA
04/2013
1MicroRNAs (MicroRNA)IBA
11/2012
1Transcription Factors (Transcription Factor)IBA
10/2012
1tissue-factor-pathway inhibitor 2 (PP5)IBA
04/2012
1Histones (Histone)IBA
12/2011
1entinostat (MS 275)IBA
12/2011
1Genetic Markers (Genetic Marker)IBA
04/2010
1Glutamic Acid (Glutamate)FDA Link
02/2010

Therapy/Procedure

9Therapeutics
01/2020 - 01/2005
7Drug Therapy (Chemotherapy)
02/2022 - 01/2005
3Esophagectomy
05/2015 - 05/2002
3Neoadjuvant Therapy
05/2015 - 12/2009
2Immunotherapy
01/2020 - 01/2017
2Segmental Mastectomy (Lumpectomy)
04/2016 - 03/2008
1Gastroenterostomy
02/2022
1Gastrectomy
02/2022
1Euthanasia (Mercy Killing)
01/2022
1Sympathectomy (Sympathectomies)
11/2018
1Length of Stay
07/2016
1Tracheostomy
04/2016
1Time-to-Treatment
05/2014
1Investigational Therapies (Experimental Therapy)
11/2013
1Heterologous Transplantation (Xenotransplantation)
11/2011